doxorubicin liposome

Known as: pegylated liposomal doxorubicin, Liposomal Doxorubicin, doxorubicin liposomal 
 

Topic mentions per year

Topic mentions per year

1997-2017
05019972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
PURPOSE This randomized, multicenter, phase III noninferiority trial was designed to test the efficacy and safety of the… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE The objective of this study was to compare the efficacy and safety of trabectedin plus pegylated liposomal doxorubicin… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE This phase III international study compared the efficacy and safety of a combination of pegylated liposomal doxorubicin… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE Ovarian cancer (OC) patients experiencing progressive disease (PD) within 6 months of platinum-based therapy in the… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Pharmacokinetic studies on liposomal drugs have previously measured total drug levels in tumors, which include non… (More)
  • figure 1
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND This study was designed to demonstrate that efficacy [progression-free survival (PFS)] of CAELYX [pegylated liposomal… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Provide long-term follow-up data for women treated in a randomized multicenter study of pegylated liposomal doxorubicin… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE To compare the efficacy and safety of pegylated liposomal doxorubicin (PLD) and topotecan in patients with epithelial… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
CAELYX/DOXIL, pegylated liposomal doxorubicin, has shown antitumour activity and reduced toxicity compared with standard… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Doxil (ALZA Corp., Mountain View, CA) is a formulation of doxorubicin in polyethylene-glycol coated liposomes with a… (More)
Is this relevant?